Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Seoul National University Hospital
Seoul National University Hospital
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
University of Washington
Washington University School of Medicine
The Lymphoma Academic Research Organisation
Northside Hospital, Inc.
Northside Hospital, Inc.
University of California, San Francisco
Fred Hutchinson Cancer Center
Heidelberg University
Fondazione Italiana Linfomi - ETS
Shanghai Jiao Tong University School of Medicine
M.D. Anderson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Washington
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Beijing Tongren Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Yale University
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
St. Jude Children's Research Hospital
University of California, Davis
Massachusetts General Hospital
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
Alliance Foundation Trials, LLC.
University of Utah
Dana-Farber Cancer Institute
International Extranodal Lymphoma Study Group (IELSG)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Hoosier Cancer Research Network